SonALAsense Revenue and Competitors
Estimated Revenue & Valuation
- SonALAsense's estimated annual revenue is currently $3.6M per year.
- SonALAsense's estimated revenue per employee is $155,000
Employee Data
- SonALAsense has 23 Employees.
- SonALAsense grew their employee count by 5% last year.
SonALAsense's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Founder and Chief Scientific Officer | Reveal Email/Phone |
3 | Chief Financial Officer & Chief Operations Officer | Reveal Email/Phone |
4 | CMO and EVP Development | Reveal Email/Phone |
5 | Sr. VP, Clinical Operations at SonALAsense | Reveal Email/Phone |
6 | Director, Project Management | Reveal Email/Phone |
SonALAsense Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is SonALAsense?
SonALAsense is a clinical-stage company developing ALA sonodynamic therapy (SDT) as a first-in-class, non-invasive drug-device combination for the treatment of recurrent glioblastoma multiforme (rGBM) and other deadly cancers. SDT utilizes MRI-guided focused ultrasound (the device) in combination with aminolevulinic acid (a drug) to selectively target and kill tumor cells.
keywords:N/AN/A
Total Funding
23
Number of Employees
$3.6M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 23 | -8% | N/A |
#2 | $2.3M | 23 | -32% | N/A |
#3 | $1.8M | 23 | 10% | N/A |
#4 | $2.3M | 23 | 5% | N/A |
#5 | $2.3M | 23 | 5% | N/A |